OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026
Rhea-AI Summary
OSR Holdings (NASDAQ:OSRH) will present strategic updates at the Emerging Growth Conference on April 1, 2026 at 4:25 p.m. ET. The virtual presentation will review recent milestones including the VXM01 oncology asset and Woori IO noninvasive glucose monitoring platform, followed by Q&A.
A live registration link and archived webcast access are provided for investors and analysts who cannot attend live.
Positive
- None.
Negative
- None.
News Market Reaction – OSRH
In the Mar 30 session, OSRH gained 13.84%, reflecting a significant positive market reaction. Argus tracked a peak move of +26.5% during that session. Our momentum scanner triggered 19 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 27 | Analyst flash report | Positive | +5.6% | Buy-Emerging rating reaffirmed with $10.00 12-month price target and deal highlights. |
| Mar 23 | Licensing deal update | Positive | +9.6% | Revised VXM01 license structure with up to $815M milestones and $30M facility. |
| Mar 19 | Sinopharm NDA signed | Positive | +2.4% | Mutual NDA with Sinopharm for noninvasive glucose monitoring and China pathway evaluation. |
| Mar 19 | China opportunity detail | Positive | +2.4% | Further detail on Sinopharm NDA and large China diabetes and device market potential. |
| Mar 05 | Nasdaq extension | Positive | +14.7% | 180-day Nasdaq bid-price extension and reiterated VXM01 and device platform priorities. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news on licensing, NDAs, analyst coverage, and Nasdaq compliance has consistently coincided with positive price reactions, indicating a pattern of strong responses to strategic and credibility-building developments.
Over the last month, OSRH has highlighted multiple strategic steps: a flash research report reaffirming a Buy‑Emerging rating with a $10.00 target, a restructured VXM01 licensing deal with up to $815 million in milestones, and NDAs with Sinopharm around Woori IO’s glucose monitoring platform. The company also secured a 180‑day Nasdaq bid‑price extension to August 31, 2026. Today’s investor conference update fits this pattern of sustained outreach and deal-focused communication.
Key Terms
oncology medical
noninvasive glucose monitoring medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BELLEVUE, WA / ACCESS Newswire / March 30, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company advancing biomedical innovations to improve health and wellness worldwide, today announced that management will present at the upcoming Emerging Growth Conference. The presentation will provide investors and analysts with an updated overview of the Company's recent strategic milestones - including its VXM01 oncology asset and Woori IO's noninvasive glucose monitoring platform - and its outlook for continued growth.
Virtual Presentation Details
Date: April 1, 2026
Time: 4:25 p.m. ET
Format: Strategic Updates and Q&A
Registration: https://goto.webcasts.com/starthere.jsp?ei=1748971&tp_key=add80b0ab6&sti=osrh
Mr. Tim Smith, Head of Investor Relations, will present the Company's strategic updates, followed by a question-and-answer session, time permitting. Investors are encouraged to submit questions in advance to Questions@EmergingGrowth.com or during the live event and management will address as many questions as possible.
To view the Company's previous presentation, visit: https://www.youtube.com/watch?v=nDaVqSE_GhU&t=651s
Attendees are encouraged to register in advance. For those unable to attend live, an archived webcast will be available at www.EmergingGrowth.com, the Emerging Growth YouTube Channel, and in the "Events & Presentations" section of the Company's website www.OSR-Holdings.com.
About the Emerging Growth Conference
The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.
The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.
All sessions will be conducted through video webcasts and will take place in the Eastern time zone.
About OSR Holdings
OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSRH engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at www.OSR-Holdings.com.
Investor Contact
OSR Holdings, Inc.
Investor Relations
ir@osr-holdings.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable U.S. securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially, including those described in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements, except as required by law.
SOURCE: OSR Holdings, Inc.
View the original press release on ACCESS Newswire